The vaccine prevents against two strains of the human papilloma virus which cause cervical, anal and penis cancers. The clinical trial was funded by the vaccine’s maker, Merck, presumably in order to pave the way toward approving its use in men in Canada — and ultimately to see it approved in the U.S. 

“The numbers right now look not quite as good as the girls’ but still very, very good,” says [lead researcher Joel] Palefsky. “The vaccine was nearly 100 percent effective [in women] so you obviously can’t do better than that.”

Gay men are 17 times more likely to develop anal cancer than straight men, due to anal sexual contact. It’s important to note, though that one can contract HPV on the anus without having anal intercourse. 

Between this and the AIDS-stopping mangina gel, the next generation of young gays are really going to have no reason not be complete whores.

RELATED:

Get Herpes, Become $6.7 Million Richer
New Gel May Stop HIV Infection In the Mangina
AIDS Skeptic Dies of AIDS
High-Grade Pot May Cure ‘Gay Staph’

HPV vaccine effective in men, suggests new research (Xtra.ca)